Navigation Links
AACR nomination of Harold E. Varmus, M.D., as director of the NCI

PHILADELPHIA The American Association for Cancer Research, the world's oldest and largest cancer research organization, congratulates Harold E. Varmus, M.D., on his nomination by President Barack Obama to serve as the 14th director of the National Cancer Institute (NCI).

"Dr. Varmus will bring to the NCI an unrivaled appreciation for how basic science serves as the foundation for understanding healthy function as well as disease conditions," said Elizabeth H. Blackburn, Ph.D., president of the AACR. "His visionary leadership will allow NCI to continue leading the way in programs aimed at preventing disease, improving health and reducing suffering from cancer."

"This is a great day for cancer research. It is hard to imagine someone more qualified for this position," added Tyler Jacks, Ph.D., past president of the AACR. "Dr. Varmus has a tremendous wealth of experience, an abundance of good ideas and almost unlimited energy. The AACR looks forward to working with Dr. Varmus in the months and years to come."

"Cancer research is advancing at a staggering pace. Dr. Varmus' extraordinary vision and leadership will be vitally important in our efforts to further reduce cancer incidence and mortality," added Margaret Foti, Ph.D., M.D. (h.c.), chief executive officer of the AACR. "As Dr. Varmus takes the helm of the NCI, the AACR is confident that we will accelerate the pace of discovery research and translational research, and thereby bring hope and improved survival to cancer patients everywhere."

Varmus, a Nobel Prize Laureate and former head of the National Institutes of Health, most recently served as president and chief executive officer of the Memorial Sloan-Kettering Cancer Center, New York.

He, along with J. Michael Bishop, M.D., and colleagues demonstrated the cellular origins of the oncogene of a chicken retrovirus, which led to the isolation of many cellular genes that normally control growth and development and are frequently mutated in human cancer. For this work, they won the 1989 Nobel Prize for Physiology or Medicine.

Varmus is also recognized for his studies of the replication cycles of retroviruses and hepatitis B viruses, the functions of genes implicated in cancer, and the development of mouse models of human cancer.

Varmus was named by President Clinton to serve as the director of the National Institutes of Health, a position he held from 1993 to 1999. He was appointed by President Barack Obama as co-chair of the President's Council of Advisors on Science and Technology. Additionally, Varmus served on the World Health Organization's Commission on Macroeconomics and Health from 2000 to 2002; is a co-founder and chairman of the Board of Directors of the Public Library of Science, a publisher of open access journals in the biomedical sciences; and chaired the Scientific Board of the Grand Challenges in Global Health at the Bill and Melinda Gates Foundation from 2003 to 2008 where he now chairs the Foundation's Global Health Advisory Committee. He is a member of the National Academy of Sciences and the Institute of Medicine. He has received the National Medal of Science, the Vannevar Bush Award and several honorary degrees and other prizes.

Varmus will succeed John E. Niederhuber, M.D., director of the NCI since 2006. In addition to his leadership at the NCI, over the course of his career, Niederhuber has supported the advancement of cancer research as a professor, cancer center director, National Cancer Advisory Board chair, external advisor to the NCI, grant reviewer and laboratory investigator.


Contact: Michele Leiberman
American Association for Cancer Research

Related biology news :

1. AACR applauds nomination of Francis S. Collins, M.D., Ph.D., to be the new NIH director
2. Harold Mooney and Peter Raven, winners of the BBVA Foundation Award for Conservation Biology
3. Harold Mooney wins prestigious Tyler Prize for Environmental Achievement
4. Sihoun Hahn, M.D., Ph.D., FACMG is the 2009-2010 Luminex/ACMGF Award recipient
5. Jonathan Berg, M.D., Ph.D. awarded Richard King Trainee Award for Best in Genetics in Medicine
6. Georgetown Universitys Howard J. Federoff, M.D., Ph.D. receives Bernard Sanberg Memorial Award
7. Dr. Marilyn M. Li, M.D., FACMG, is the 2010 Luminex/ACMGF award recipient
8. Gregory Downey, M.D., of National Jewish Health, honored for scientific accomplishments
9. Michael A. Betts, Seasoned Financial Services Executive, Joins CIC Board of Directors
10. Office of the Director of National Intelligence, CIO to Speak at Government Security Conference
11. Director of National Intelligence to Speak at Conference
Post Your Comments:
(Date:11/18/2015)... York , November 18, 2015 ... Research has published a new market report titled  Gesture ... Trends, and Forecast, 2015 - 2021. According to the report, ... 2014 and is anticipated to reach US$29.1 bn by ... 2021. North America dominated ...
(Date:11/17/2015)... November 17, 2015 Paris ... 2015.  --> Paris , qui ... DERMALOG, le leader de l,innovation biométrique, a inventé ... passeports et empreintes sur la même surface de balayage. ... et l,autre pour les empreintes digitales. Désormais, un seul ...
(Date:11/17/2015)... SOUTH EASTON, Mass. , Nov. 17, 2015 /PRNewswire/ ... "Company"), a leader in the development and sale of ... to the worldwide life sciences industry, today announced it ... closing of its $5 million Private Placement (the "Offering"), ... Offering to $4,025,000.  One or more additional closings are ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... --> --> ... by Transparency Market Research, the global non-invasive prenatal testing ... 17.5% during the period between 2014 and 2022. The ... Analysis, Size, Volume, Share, Growth, Trends and Forecast 2014 ... to reach a valuation of US$2.38 bn by 2022. ...
(Date:11/24/2015)... , ... November 24, 2015 , ... ... the environment are paramount. Insertion points for in-line sensors can represent a weak ... the InTrac 781/784 series of retractable sensor housings , which are designed ...
(Date:11/24/2015)... Capricor Therapeutics, Inc. (NASDAQ: ... development and commercialization of first-in-class therapeutics, today announced that ... scheduled to present at the 2015 Piper Jaffray Healthcare ... at The Lotte New York Palace Hotel in ... . --> . ...
(Date:11/24/2015)... ... , ... Whitehouse Laboratories is pleased to announce that it has completed construction ... dedicated to basic USP 61, USP 62 and USP 51 testing specific to raw ... and micro testing performed by one supplier. Management has formally announced that ...
Breaking Biology Technology: